Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis

In Vitro Cellular and Developmental Biology - Animal

Volumn 32, Issue 10, 1996, Pages 627-632

  Opperman, Lynne A ^a   Passarelli, Ralph W ^a   Nolen, Amber A ^a   Gampper, Thomas J ^a   Lin, Kant Y K ^a   Ogle, Roy C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

calvaria; development; growth factors; in vitro; rat

Indexed keywords

FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ARTICLE; BONE GROWTH; CALVARIA; CRANIAL SUTURE; CRANIOFACIAL DEVELOPMENT; DURA MATER; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; MINERALIZATION; MORPHOGENESIS; NONHUMAN; OSSIFICATION; PROTEIN SECRETION; RAT;

EID: 0030457783     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02724047     Document Type: Article

References (36)

1. Alberius, P.; Jonell, O, Immunohistochemical assessment of cranial suture development in rats. J. Anat. 173:61-68; 1990.
2. Baer, M. J. Patterns of growth of the skull as revealed by vital staining. Hum. Biol. 26:80-126; 1954.
3. Burgess, W. H.; Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Ann. Rev. Biochem. 58:575-606; 1989.
4. Centrella, M.; Massague, J.; Canalis, E. Human platelet-derived transforming growth factor-β stimulates parameters of bone growth in fetal rat calvaria. Endocrinology 119:2306-2312; 1986.
5. Cohen, M. M., Jr. Suturai biology and the correlates of craniosynostosis. Am. J. Med. Genet. 47:581-616; 1993.
6. Couly, G. F.; Coltey, P. M.; Le Douarin, N. M. The developmental fate of the cephalic mesoderm in quail-chick chimeras. Development 114:1-15; 1992.
7. Couly, G. F.; Coltey, P. M.; Le Douarin, N. M. The triple origin of skull in higher vertebrates. Development 117:40-429; 1993.
8. D'Amore, P. Modes of FGF release in vivo and in vitro. Cancer Met. Rev. 9:227-238; 1990.
9. Dionne, C. A.; Crumley, A.; Bellot, F., et al. Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9:2685-2692; 1990.
10. Drake, D. B.; Persing, J. A.; Berman, D. E., et al. Calvarial deformity regeneration following subtotal calvariectomy for craniosynostosis: a case report and theoretical implications. J. Craniofac. Surg. 4:85-89; 1993.
11. Enlow, D. H. Normal and abnormal patterns of craniofacial growth. In: Persing, J. A.; Edgerton, M. T.; Jane, J. A. (Eds). Sc ientific Foundations and Surgical Treatment of Craniosynostosis. Williams and Wilkins, Baltimore: 83-86; 1989.
12. Frenkel, S. R.; Grande, D. A.; Collins, M., et al. Fibroblast growth factor in chick osteogenesis. Biomaterials 11:38-40; 1990.
13. Frenkel, S. R.; Herskovits, M. S.; Singh, I. J. Fibroblast growth factor: effect on osteogenesis and chondrogenesis in the chick embryo. Acta Anat. 145:265-268; 1992.
14. Jabs, E. W.; Muller, U.; Li, X., et al. A mutation in the homeodomain of the human msx2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75:443-450; 1993.
15. Jabs, E. W.; Li, X.; Scott, A. F., et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast receptor 2. Nature Genet. 8:275-279; 1994.
16. Kasperk, C. H.; Wergedal, J. E.; Mohan, S., et al. Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Fact. 3:147-158; 1990.
17. Liu, Y. H.; Kundu, R.; Wu, L., et al. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc. Natl. Acad. Sci. USA 92:6137-6141; 1995.
18. Mabbutt, L. W.; Kokich, V. G. Calvarial and sutural redevelopment following craniectomy in the neonatal rabbit. J. Anat. 2:413-422; 1979.
19. McCaffrey, T. A.; Falcone, D. J.; Du, B. Transforming growth factor-β1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1. J. Cell. Physiol. 152:430-140; 1992.
20. Melcher, A. H. Cells from soft connective tissue depress osteogenesis in vitro. In: Davidovich, Z., ed. The biological mechanisms of tooth eruption and root resorption. Birmingham, AL: EBSCO Media; 1988:87-91.
21. Miki, T.; Bottaro, D. P.; Fleming, T. P., et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA 89:246-250; 1992.
22. Moss, M. L. Inhibition and stimulation of sutural fusion in the rat calvaria. Anat. Rec. 136:457-467; 1960.
23. Muenke, M.; Schell, U.; Hehr, A., et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet. 8:269-274; 1994.
24. Ogiso, B.; Hughes, F. J.; Melcher, A. H., et al. Fibroblasts inhibit mineralized bone nodule formation by rat bone marrow stromal cells in vitro. J. Cell. Physiol. 146:442-450; 1991.
25. Opperman, L. A.; Passarelli, R. W.; Morgan, E. P., et al. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J. Bone Min. Res. 12:1978-1987; 1995.
26. Opperman, L. A.; Persing, J. A.; Sheen, R., et al. In the absence of periosteum, fetal and neonatal coronal sutures resist osseous obliteration in a rat transplant model. J. Craniofac. Surg. 5:327-332; 1994.
27. Opperman, L. A.; Saunders, T. J.; Bruns, D. E., et al. Estrogen inhibits calbindin-D28k expression in mouse uterus. Endocrinology 130:1728-1735; 1992.
28. Opperman, L. A.; Sweeney, T. M.; Redmon, J., et al. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dynam. 198:312-322; 1993.
29. Orr-Uretreger, A.; Bedford, M. T.; Burakova, T., et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor2 (FGFR2). Dev. Biol. 158:475-486; 1993.
30. Orr-Uretreger, A.; Givol, D ; Yahon, A., et al. Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113:1419-1434; 1991.
31. Reardon, W.; Winter, R. M.; Rutland, P., et al. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet. 8:98-103; 1994.
32. Roth, D. A.; Longaker, M. T.; Breitbart, A. S., et al. The role of transforming growth factor beta-1 in rat cranial suture fusion. 63rd Annual Scientific Meeting ASPRS-PSEF-ASMS, San Diego, California, September, 1994: 39-40.
33. Smith, D. W.; Tondury, G. Origin of the calvaria and its sutures. Am. J. Dis. Child. 132:662-666; 1978.
34. ten Dijke, P.; Iwata, K. K.; Goddard, C., et al. Recombinant transforming growth factor type β3: biological activities and receptor-binding properties in isolated bone cells. Mol. Cell. Biol. 10:4473-4479; 1990.
35. Wilkie, A. O. M.; Slaney, S. F.; Oldridge, M., et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet. 9:165-172; 1995.
36. Yahon, A.; Zimmer, Y.; Guo-Hong, S., et al. A confined variable region confers ligand binding specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J. 11:1885-1890; 1992.